135 related articles for article (PubMed ID: 11736930)
1. Factor IX and thrombosis.
Lowe GD
Br J Haematol; 2001 Dec; 115(3):507-13. PubMed ID: 11736930
[No Abstract] [Full Text] [Related]
2. Properties of commercial factor IX concentrates.
Coan MH; Fournel MA; Mozen MM
Ann N Y Acad Sci; 1981; 370():731-46. PubMed ID: 6168231
[No Abstract] [Full Text] [Related]
3. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly.
Mertens K; Celie PH; Kolkman JA; Lenting PJ
Thromb Haemost; 1999 Aug; 82(2):209-17. PubMed ID: 10605706
[No Abstract] [Full Text] [Related]
5. Tissue factor and thrombosis: The clot starts here.
Owens AP; Mackman N
Thromb Haemost; 2010 Sep; 104(3):432-9. PubMed ID: 20539911
[TBL] [Abstract][Full Text] [Related]
6. The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.
Buyue Y; Whinna HC; Sheehan JP
Blood; 2008 Oct; 112(8):3234-41. PubMed ID: 18647957
[TBL] [Abstract][Full Text] [Related]
7. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
Niiya K; Hirose S; Taguchi H; Miyoshi I
Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
[No Abstract] [Full Text] [Related]
8. Activation of factor IX by factor XIa.
Gailani D
Trends Cardiovasc Med; 2000 Jul; 10(5):198-204. PubMed ID: 11282295
[TBL] [Abstract][Full Text] [Related]
9. A rare case of an acquired inhibitor to factor IX.
Krishnamurthy P; Hawche C; Evans G; Winter M
Haemophilia; 2011 Jul; 17(4):712-3. PubMed ID: 21371188
[No Abstract] [Full Text] [Related]
10. Regulation of the initiation of coagulation by factor VII.
Nemerson Y
Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.
Griffith MJ; Breitkreutz L; Trapp H; Briet E; Noyes CM; Lundblad RL; Roberts HR
J Clin Invest; 1985 Jan; 75(1):4-10. PubMed ID: 3871202
[TBL] [Abstract][Full Text] [Related]
12. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.
Bajaj SP
Thromb Haemost; 1999 Aug; 82(2):218-25. PubMed ID: 10605707
[TBL] [Abstract][Full Text] [Related]
13. Cancer Therapy-Associated Thrombosis.
Grover SP; Hisada YM; Kasthuri RS; Reeves BN; Mackman N
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1291-1305. PubMed ID: 33567864
[TBL] [Abstract][Full Text] [Related]
14. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
[TBL] [Abstract][Full Text] [Related]
15. Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).
Taylor SA; Deugau KV; Lillicrap DP
Proc Natl Acad Sci U S A; 1991 Jan; 88(1):39-42. PubMed ID: 1986380
[TBL] [Abstract][Full Text] [Related]
16. [The current feature of the study on human coagulation factor IX mutant].
Yan JB
Yi Chuan; 2005 Sep; 27(5):833-8. PubMed ID: 16257919
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?
Carroll BJ; Piazza G
Vasc Med; 2018 Aug; 23(4):388-399. PubMed ID: 30045685
[TBL] [Abstract][Full Text] [Related]
18. The multiple levels of endothelial cell-coagulation factor interactions.
Nawroth PP; Handley D; Stern DM
Clin Haematol; 1986 May; 15(2):293-321. PubMed ID: 3524930
[No Abstract] [Full Text] [Related]
19. Immune reactive factor IX in acquired factor IX deficiency.
Lechner K
Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
[No Abstract] [Full Text] [Related]
20. Factor IX of the blood coagulation system: a review.
Taran LD
Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
